AVKARE Inc. has recalled approximately 237 cartons of Lovastatin (lovastatin) Tablets USP, 40 mg, used for treating high cholesterol. This recall was initiated because the medication failed stability testing for dissolution, meaning the tablets may not dissolve properly in the body. If the drug does not dissolve as intended, it may not be fully absorbed, which could reduce the effectiveness of the treatment. The affected products were distributed nationwide in the USA in 50-tablet unit dose cartons.
The failure to meet dissolution standards means the medication might not be absorbed into the bloodstream at the correct rate or amount. This can result in the patient receiving a lower dose of the active ingredient than prescribed, potentially leading to poorly managed cholesterol levels.
Drug recall return and consultation
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.